You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 3.0% | 3.2% |
| Div Cover | 3.8 | 3.6 |
| Op Mrgn | 13.2% | 23.1% |
| ROCE | 46.4% |
| Latest | Forecast | |
|---|---|---|
| P/E | 8.7 | 8.7 |
| PEG | 0.3 | -18.6 |
| Price / Revenue | 1.8 | 1.6 |
| Price / Book value | 1.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 25.7% | 1.9% |
| PBT | 39.5% | n/a |
| EPS | 25.0% | -0.4% |
| DPS | 5.0% | 5.4% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 101.64 | 28.29 | 5.33p | 12.6 | 0.3 | 38% | 1.33p | 2.0% |
| 2018-12-31 | 118.21 | 22.80 | 4.54p | 14.8 | -1.0 | -15% | 1.46p | 2.2% |
| 2019-12-31 | 135.64 | 31.08 | 5.09p | 16.5 | 1.4 | 12% | 0.54p | 0.6% |
| 2020-12-31 | 129.80 | 13.02 | 5.11p | 17.1 | 43.6 | 0% | 1.61p | 1.8% |
| 2021-12-31 | 163.21 | 18.16 | 6.39p | 17.0 | 0.7 | 25% | 1.69p | 1.6% |
| Alliance Pharma revenue rises, profits narrow in first half Sharecast News | 20 Sep |
|---|---|
| Alliance Pharma appeals competition disqualification order Sharecast News | 02 Sep |
| Alliance Pharma shares slide following challenging H1 Sharecast News | 20 Jul |
| Total Voting Rights | 04-Oct-22 23:59 |
|---|---|
| NOTIFICATION OF MAJOR HOLDINGS | 03-Oct-22 23:59 |
| Grant of Options to Directors | 30-Sep-22 16:12 |
| Interim Results | 20-Sep-22 07:01 |
| Update on CMA investigation | 02-Sep-22 07:07 |